Clinical Trial Update: Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing cisplatin, pemetrexed disodium, and radiation therapy followed by docetaxel in stage III non-small cell lung cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-13